April 13, 2021 Comments Off on New patent for Actelion Pharms drug OPSUMIT Posted in: Patent Added Annual Drug Patent Expirations for OPSUMIT Opsumit is a drug marketed by Actelion Pharms Ltd and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Actelion Pharms drug OPSUMIT appeared first on DrugPaten…
April 13, 2021 Comments Off on New patent for Astrazeneca Ab drug BYDUREON PEN Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fi…
